Sexually Transmitted Infection Panel Coming Soon*

The CDC estimates that 1 in 5 Americans has a sexually transmitted infection (STI).¹ PRL's new STI panel simultaneously detects pathogens that cause chlamydia, gonorrhea and trichomoniasis, three of the most common STIs.²

Trichomonas vaginalis (TV)

TV is the parasite that causes trichomoniasis, an STI that can cause complications in pregnant women such as premature delivery.³ Symptoms in women can also include vaginal discharge, genital itching and painful urination.³ Although infection rates in both men and women are similar, women are typically symptomatic, while men are usually asymptomatic.³

Neisseria gonorrhoeae (NG)

NG is the bacterium that causes gonorrhea, the second most commonly reported bacterial STI in the U.S.⁴ Untreated, gonorrhea can cause serious and permanent health problems in both women and men.⁴ Although 1.6 million new cases were reported in 2018, many men and most women with gonorrhea are asymptomatic and are unaware that they have the disease.⁴

Chlamydia trachomatis (CT)

CT is the bacterium that causes chlamydia, the most commonly diagnosed STI.⁵ It is known as a silent epidemic due to the fact that about 75% of infected women and 50% of men display no symptoms.⁵⁻⁶ If left untreated, CT can lead to chronic pelvic pain, ectopic pregnancy and/or infertility.⁵

Molecular PCR Testing for STIs

Nucleic Acid Amplification Testing is the recommended method to screen and diagnose most STIs.⁷ Simultaneous testing of multiple targets helps inform appropriate treatment decisions and reduce misuse of antibiotics.

Improve Patient Management

In most cases, symptoms alone are not enough for a healthcare professional to diagnose an STI. Traditional testing may lack sensitivity, specificity and speed. Newer molecular methods offer rapid, cost-efficient and reliable avenues to improve clinical management for patients.⁸

Stop Asymptomatic Spread

Since many people with STIs are asymptomatic and spread infections unknowingly, routine testing allows medical professionals to quickly diagnose, properly treat, prevent a condition from worsening and mitigate a potential outbreak.

Identify Co-Infection

When a patient is diagnosed with an STI, there's a higher chance of contracting and transmitting other STIs.⁹ Patients with gonorrhea, for example, are often co-infected with chlamydia.¹⁰ Simultaneous testing for multiple targets eliminates serial testing and can help identify cases of co-infection sooner.

Screen High-Risk Groups

Increased accessibility of molecular testing can aid in the routine monitoring of STIs, further preventing outbreaks in high-risk individuals, such as residents of a senior care facility.

Multiplex Nucleic Acid Amplification Testing for Sexually Transmitted Infections

Download White Paper


Which PRL lab(s) offer the STI panel?
What pathogens are targeted in the STI panel?
How much does the PRL STI Panel cost?
What sample types are accepted for the STI Panel?
What is the regulatory status of the STI Panel?
How accurate is the STI Panel?
What is the anticipated turnaround time for the STI Panel?
What is the CPT billing code for the STI Panel?
Is PRL CLIA certified?
Where can I find PRL?
Which states can submit samples to our Rockville, MD CLIA lab?
Which states can submit samples to our Irvine, CA CLIA lab?
Which states can submit samples to our Long Island City, NY CLIA lab?

Our other offerings

Rapid, low-cost infectious disease and routine health tests

Rapid response for isolation, quarantine and treatment decisions.

Quick rule-in or rule-out of infections with similar cold/flu-like symptoms.

Thyroid Health Panel (Coming Soon)*

Screen for a number of thyroid hormones to diagnose conditions such as hyperthyroidism and hypothyroidism.

  1. STI incidence, prevalence, cost estimates. Centers for Disease Control and Prevention. Published January 25, 2021. Accessed May 25, 2022.
  2. CDC - STD Diseases & Related Conditions. Centers for Disease Control and Prevention. Published December 8, 2021. Accessed June 27, 2022.
  3. Trichomoniasis. Mayo Clinic. Published May 17, 2022. Accessed June 27, 2022.
  4. Gonorrhea – CDC Detailed Fact Sheet. Centers for Disease Control and Prevention.,abdominal%20pain%20and%20fever%2013. Published April 12, 2022. Accessed June 27, 2022.
  5. Chlamydia – CDC Detailed Fact Sheet. Centers for Disease Control and Prevention. Published April 12, 2022. Accessed June 27, 2022.
  6. Nazario B. Chlamydia: Symptoms (men & women), diagnosis, treatment. WebMD. Published August 21, 2020. Accessed June 27, 2022.
  7. Cosentino LA, Campbell T, Jett A, et al. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. Journal of Clinical Microbiology. 2012;50(6):2005-2008. doi:10.1128/jcm.00185-12
  8. Muralidhar S. Molecular methods in the laboratory diagnosis of sexually transmitted infections. Indian Journal of Sexually Transmitted Diseases and AIDS. 2015;36(1):9. doi:10.4103/0253-7184.156686
  9. HIV and sexually transmitted diseases (stds). National Institutes of Health. Published August 26, 2021. Accessed June 27, 2022.
  10. Gonorrhea/Chlamydia Co-Infection . Published February 2013. Accessed June 27, 2022.

*Upcoming test panels are in development and subject to future modifications and/or regulatory review.

PRL provides nationwide, industrial-scale diagnostic testing for COVID-19, infectious diseases and routine health, plus non-diagnostic sequencing for variant detection.

© 2022 PRL. All rights reserved.
Pandemic Response Lab 45-18 Ct Square West Long Island City, NY 11101 Hours: Open 24/7 CLIA# 33D2196459 CAP# 9038601
Pandemic Response Lab 9605 Medical Center Dr. Suite 220 Rockville, MD 20850 Hours: Mon-Sat, 9AM-9:30PM EST CLIA# 21D2215498 CAP# 9075286
131 Innovation Drive, Suite 150 Irvine, CA 92617 Hours: Open 24/7 CLIA# 05D2230382
Customer Support (888) 672-3144
© 2022 PRL. All rights reserved.